{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:08:55Z","timestamp":1778800135862,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,7]],"date-time":"2027-05-07T00:00:00Z","timestamp":1809648000000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA240139"],"award-info":[{"award-number":["P30CA240139"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA189295-01"],"award-info":[{"award-number":["1R01CA189295-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018896","name":"Sylvester Comprehensive Cancer Center, University of Miami Health Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027385","name":"Southeastern Connecticut Cultural Coalition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.urolonc.2026.111096","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:31:23Z","timestamp":1775712683000},"page":"154-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer"],"prefix":"10.1016","volume":"44","author":[{"given":"Seyed Hossein Hosseini","family":"Sharifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4571-1944","authenticated-orcid":false,"given":"Jonathan T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Tapia-Stoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Bitaraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Abdshah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nachiketh","family":"Soodana-Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archan","family":"Khandekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya","family":"Swain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr N.","family":"Kryvenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radka","family":"Stoyanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia R.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad R.","family":"Ritch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Kava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Gonzalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipen J.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanoj","family":"Punnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2026.111096_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eururo.2025.03.019","article-title":"Magnetic resonance imaging-led risk-adapted active surveillance for prostate cancer: updated results from a large cohort study","volume":"88","author":"Englman","year":"2025","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111096_bib0002","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.eururo.2014.10.010","article-title":"Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification","volume":"67","author":"Loeb","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111096_bib0003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21037\/tau.2017.12.24","article-title":"Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices","volume":"7","author":"Kinsella","year":"2018","journal-title":"Transl Androl Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111096_bib0004","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrclinonc.2014.69","article-title":"Multiparametric MRI in prostate cancer management","volume":"11","author":"Johnson","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2026.111096_bib0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.urolonc.2026.111096_bib0006","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111096_bib0007","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.eururo.2020.03.035","article-title":"Five-year outcomes of magnetic resonance imaging\u2013based active surveillance for prostate cancer: a large cohort study","volume":"78","author":"Stavrinides","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111096_bib0008","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1007\/s00330-020-07256-z","article-title":"Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort","volume":"31","author":"Giganti","year":"2021","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111096_bib0009","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41391-018-0058-5","article-title":"The natural history of prostate cancer on MRI: lessons from an active surveillance cohort","volume":"21","author":"Giganti","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111096_bib0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN Guidelines\u00ae insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw: JNCCN"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111096_bib0011","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/JU.0000000000001547","article-title":"Magnetic resonance imaging-targeted and systematic biopsy for detection of grade progression in patients on active surveillance for prostate cancer","volume":"205","author":"Yerram","year":"2021","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111096_bib0012","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/bju.14358","article-title":"Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis","volume":"122","author":"Schoots","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.111096_bib0013","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.urology.2019.08.035","article-title":"Systematic biopsy does not contribute to disease upgrading in patients undergoing targeted biopsy for PI-RADS 5 lesions identified on magnetic resonance imaging in the course of active surveillance for prostate cancer","volume":"134","author":"Arabi","year":"2019","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111096_bib0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.euf.2019.05.011","article-title":"Outcomes of serial multiparametric magnetic resonance imaging and subsequent biopsy in men with low-risk prostate cancer managed with active surveillance","volume":"7","author":"Hsiang","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111096_bib0015","first-page":"34","article-title":"Targeted biopsy is sufficient for men on active surveillance for early-stage prostate cancer","volume":"213","author":"Fakunle","year":"2025","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111096_bib0016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2016.08.023","article-title":"Magnetic resonance imaging-ultrasound fusion biopsy during prostate cancer active surveillance","volume":"72","author":"Tran","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111096_bib0017","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/JU.0000000000001307","article-title":"PI-RADS\u00ae category as a predictor of progression to unfavorable risk prostate cancer in men on active surveillance","volume":"204","author":"Wang","year":"2020","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2026.111096_bib0018","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","article-title":"ESUR\/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training","volume":"30","author":"de Rooij","year":"2020","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111096_bib0019","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1470-2045(25)00100-7","article-title":"Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial","volume":"26","author":"Bryant","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111096_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal versus transrectal magnetic resonance imaging\u2013targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111096_bib0021","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2016.06.011","article-title":"Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations\u2014a report of a European School of Oncology Task force","volume":"71","author":"Moore","year":"2017","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111096_bib0022","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.eururo.2021.05.001","article-title":"Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis","volume":"80","author":"Rajwa","year":"2021","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926001079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926001079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:30:41Z","timestamp":1778797841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926001079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078143926001079"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111096","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}